
Sign up to save your podcasts
Or


Historical approaches to treating aortic valve disease have involved invasive open-heart surgery, which can be physically and emotionally difficult for patients who tend to be very sick and delicate to treat. But now, new minimally-invasive technologies to treat both common and complex cardiovascular diseases of the heart, including transcatheter aortic valve replacement (TAVR), are offering unique solutions to patient care.
Host Dr. Matt Birnholz welcomes a diverse range of cardiovascular disease experts, including Dr. Ian Meredith, Dr. Dean Kereiakes, Dr. Michael Reardon, Dr. Samir Kapadia, Dr. Vinod Thourani, Dr. Hemal Gada, as well as patient Allen Brady and wife Dianne. Tune in from the floor of one of the world’s largest cardiovascular conferences as we explore these advancements, including how far we’ve come, where we’re going and how we can better support hospitals as they expand the breadth of care for patients.
By ReachMD4
11 ratings
Historical approaches to treating aortic valve disease have involved invasive open-heart surgery, which can be physically and emotionally difficult for patients who tend to be very sick and delicate to treat. But now, new minimally-invasive technologies to treat both common and complex cardiovascular diseases of the heart, including transcatheter aortic valve replacement (TAVR), are offering unique solutions to patient care.
Host Dr. Matt Birnholz welcomes a diverse range of cardiovascular disease experts, including Dr. Ian Meredith, Dr. Dean Kereiakes, Dr. Michael Reardon, Dr. Samir Kapadia, Dr. Vinod Thourani, Dr. Hemal Gada, as well as patient Allen Brady and wife Dianne. Tune in from the floor of one of the world’s largest cardiovascular conferences as we explore these advancements, including how far we’ve come, where we’re going and how we can better support hospitals as they expand the breadth of care for patients.

3 Listeners

3 Listeners

0 Listeners

6 Listeners

15 Listeners

18 Listeners

0 Listeners